Increase in Demand for the Personalized Care Coupled Rise in Technological Development to Drive Precision Medicine Market in the Latin America Region : Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit According to study, “Latin America Precision Medicine Market (2018-2023)” some of the major companies that are currently working in the Latin America precision medicine market are Randox Laboratories, Abbott Laboratories, GlaxoSmithKline (GSK), Almac Group, Johnson & Johnson, Teva Pharmaceuticals Limited, CETICS Healthcare Technologies GmbH, GE Healthcare, Novartis AG, Pfizer. Precision medicine is a mixture of molecular biology procedures and system biology. It provides the right treatment to the patients at the right time. It protects patient’s health by using family health history, tailoring prevention and screening of the diseases. Its main goal is to provide better treatment mainly for cancer involving many applications of the systems to examine the cause of a patient’s infection at the molecular level and then to developing targeted treatment to tackle that patient’s disease process. Some of the other attributes include protective care, edge cost, the ability of care, inhabitant’s health and others. Some of the major technologies used in precision medicine market are pharmacogenomics, bioinformatics, gene sequencing, drug discovery technology, big data analytics,next-generation sequencing (NGS) and companion diagnostics. Drug discovery technology dominates the largest market share in the region. Additionally, based on the curative market is classified as cardiovascular, central anxious system, psychiatric disorder, cancer and virus diseases etc. Cancer curative market segment hold the maximum market share owing to higher death rate appropriate to cancer. The implementations of precision medicines are mainly impacted by various medical areas in two basic phases of therapy regimen and the molecular diagnosis. The therapy regimen includes many molecular diagnostic, definition of clinical progression and resistance, evaluation of side effects, cost of new and old drugs, selection of combination or sequential regimens and proper communication with the multidisciplinary team. The molecular diagnosis includes various testing methods of validating & interpreting clinical assays and scoring criteria with cut-offs for variables with continuous distribution in the population: it also provides solutions for properly communicating with the multidisciplinary team. The Brazilian Initiative on Precision Medicine (BIPMed) is based on a newly launched software platform. It offers public access to genomic & phenotypic data. BIPMed supports propagation and guidance in the areas of individual molecular heredity, computational ecology and others. The market of Latin America precision medicine is driven by the increasing demand for personalized medical solutions & treatments, increase advance healthcare services, favorable government laws and advancements in healthcare technology. In addition, around 31% population of the region cannot access cost-effective healthcare facilities adding the major restraint factor. Some of other restraints factors are lack of tolerably skilled healthcare workers and poor economic conditions of many countries. Nowadays, the Mexico, Brazil and Argentina are focusing on providing tailored treatment and therapies to the inhabitants, with the use of many technologies such as data analytics and NGS etc. During 2018-2023, it is estimated that the pharmaceuticals and biotech companies to drive owing to emergence of medicine discovery technologies. It is expected that Latin America precision medicine market will be reached at USD 6.4 billion, at a CAGR of 9.3 %, by 2023. In upcoming years, it is predicted that the market increasingly due to the huge investments in big analytic research and development (R & D) in the region. To know more, click on the link below: https://www.kenresearch.com/latin-america-precision-172434.html Related Reports : https://www.kenresearch.com/africa-precision-medicine-172433.html Contact Us:-Ken ResearchAnkur Gupta, Head Marketing & CommunicationsSales@kenresearch.com+91-9015378249 Post Views: 3 Tags: Latin America Central Nervous System Market Share, Latin America Precision Medicine Industry Research Report, Latin America Precision Medicine Market, Latin America Precision Medicine Market Analysis, Latin America Precision Medicine Market Challenges, Latin America Precision Medicine Market Growth, Latin America Precision Medicine Market Major Players, Latin America Precision Medicine Market Research Report, Latin America Precision Medicine Market Size, Latin America Precision Medicine Market Trends, Latin America Psychiatric Disorder Market Revenue, Market Drivers And Challenges In The Latin America Precision Medicine Market, Precision Medicine Industry In Latin America, Precision Medicine Market In Latin America